In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.
about
Multipurpose prevention technologies: the future of HIV and STI protectionA Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex VivoThe agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomavirusesGriffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancyIn Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical MucosaFirst-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.Carrageenan activates monocytes via type-specific binding with interleukin-8: an implication for design of immuno-active biomaterials.MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.Synergistic Effects of Sulfated Polysaccharides from Mexican Seaweeds against Measles Virus.Marine polysaccharides: therapeutic efficacy and biomedical applications.Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
P2860
Q26827796-D7589903-B5F9-4028-8446-C1379E63F66DQ27334384-F87D0313-ED0E-4F58-80F3-EE05DBE4E906Q35960675-1D44A824-F749-45E7-A02E-17D2AA862655Q36290533-B1D3914A-CE8F-4374-BC79-5E31A22E28EFQ36381485-6AF14535-A764-43E2-97A2-DA8C1BA937CBQ37203838-08EB4E19-B0D8-49C2-B885-A60C0F7CA1D4Q37520083-51F0B098-8FAF-4BD3-828B-C8475105BE73Q38768162-656927BD-B434-4771-ADD8-02BAAEB3194FQ40081674-7E80EA5E-654A-4202-BD49-EA84B47277FCQ40165275-3A7F3054-055F-4BC7-830E-8ECBC9F86CA0Q40491379-03F4BB53-906D-495E-84C3-2A5834B0552FQ40612557-1F44091C-8DB6-416F-9125-480E27F087ABQ41936007-657AA1D8-B5C8-41DB-AD4C-DB2FB1F86112Q58700581-2D44D7CB-4E1B-46D2-9D75-A1ACCB5BD4E3
P2860
In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@ast
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@en
type
label
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@ast
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@en
prefLabel
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@ast
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@en
P2093
P2860
P1433
P1476
In vitro and in vivo evaluatio ...... ns to prevent HPV acquisition.
@en
P2093
Aixa Rodríguez
Betsy C Herold
Brian E Ford
Guillermo Villegas
José A Fernández Romero
Keith Levendosky
Kyle Kleinbeck
Larisa Kizima
Melissa Robbiani
Michael L Cooney
P2860
P356
10.1016/J.ANTIVIRAL.2014.05.018
P577
2014-06-05T00:00:00Z